Ed Schwalbe
Northumbria University
H-index: 28
Europe-United Kingdom
Top articles of Ed Schwalbe
Bone Proteomics Method Optimization for Forensic Investigations
Journal of Proteome Research
2024/4/15
The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients
Eclinicalmedicine
2024/3/1
Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups
Ebiomedicine
2024/2/1
Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome
Neuro-oncology
2023/12/1
Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray
STAR protocols
2023/9/15
MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS
Neuro-Oncology
2023/6/1
Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development
2023/6
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta neuropathologica
2023/5
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
Haematologica
2023/3/3
The impact of maceration on the ‘Osteo-ome’; a pilot investigation
Journal of Proteomics
2023/1/16
The Idiopathic Pulmonary Fibrosis-associated single nucleotide polymorphism rs35705950 is transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979. 1)
Non-coding RNA
2022/12/8
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
British Journal of Cancer
2022/11/23
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development
Acta neuropathologica
2022/9
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
Cell reports
2022/8/2
MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma
Neuro-Oncology
2022/6/3
PATH-06. Molecular subgrouping of medulloblastoma via low-depth whole genome bisulfite sequencing
Neuro-Oncology
2022/6
MOLECULAR CHARACTERISATION OF GROUP 4 MEDULLOBLASTOMA IMPROVES RISK-STRATIFICATION AND ITS BIOLOGICAL UNDERSTANDING
2022/6/1
MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse
Neuro-Oncology
2022/6/1
MEDB-65. Molecular subclassification of a national cohort of pediatric medulloblastoma based on methylation profile
Neuro-Oncology
2022/6/1
RARE-08. Profiling of recurrent adamantinomatous cranionpharyngioma confirms the activation of the MAPK pathway and identifies copy number aberrations in relapsed tumours
Neuro-Oncology
2022/6/1